Research Article
Different Patterns of Bacterial Species and Antibiotic Susceptibility in Diabetic Foot Syndrome with and without Coexistent Ischemia
Table 3
Number of particular bacterial isolates in all patients with ischemic diabetic foot syndrome.
| | Number of isolates | Percent |
| | Staphylococcus aureus MSS | 38 | 16.10% | | Enterococcus faecalis | 26 | 11.02% | | Acinetobacter baumannii MDR | 14 | 5.93% | | Proteus mirabilis | 13 | 5.51% | | Staphylococcus aureus MLSB | 13 | 5.51% | | Staphylococcus aureus MRSA, MLSB | 11 | 4.66% | | Pseudomonas aeruginosa | 10 | 4.24% | | Enterobacter cloacae | 9 | 3.81% | | Klebsiella pneumoniae | 9 | 3.81% | | Escherichia coli | 8 | 3.39% | | Enterococcus faecalis HLAR | 7 | 2.97% | | Staphylococcus aureus MRSA | 7 | 2.97% | | Streptococcus agalactiae | 7 | 2.97% | | Acinetobacter baumannii | 6 | 2.54% | | Morganella morganii | 4 | 1.69% | | Proteus spp. | 4 | 1.69% | | Streptococcus dysgalactiae | 4 | 1.69% | | Enterococcus faecium | 3 | 1.27% | | Streptococcus mitis | 3 | 1.27% | | Streptococcus pyogenes | 3 | 1.27% | | Actinomyces naeslundii | 2 | 0.85% | | Citrobacter koseri | 2 | 0.85% | | Clostridium sporogenes | 2 | 0.85% | | Finegoldia magna | 2 | 0.85% | | Klebsiella pneumoniae ESBL | 2 | 0.85% | | Proteus vulgaris | 2 | 0.85% | | Stenotrophomonas maltophilia | 2 | 0.85% | | Streptococcus agalactiae MLSB | 2 | 0.85% | | Streptococcus constellatus | 2 | 0.85% | | Veillonella spp. | 2 | 0.85% | | Anaerococcus prevotii | 1 | 0.42% | | Bifidobacterium spp. | 1 | 0.42% | | Clostridium innocuum | 1 | 0.42% | | Enterobacter cloacae AMP C, ESBL | 1 | 0.42% | | Enterobacter cloacae ESBL | 1 | 0.42% | | Enterococcus faecium HLAR | 1 | 0.42% | | Enterococcus faecium HLAR, VRE | 1 | 0.42% | | Enterobacter aerogenes | 1 | 0.42% | | Gemella morbillorum | 1 | 0.42% | | Klebsiella oxytoca | 1 | 0.42% | | Klebsiella pneumoniae MBL MDR | 1 | 0.42% | | Klebsiella pneumoniae MDR | 1 | 0.42% | | Lactobacillus fermentum | 1 | 0.42% | | Prevotella spp. | 1 | 0.42% | | Providencia stuartii ESBL, AMP C | 1 | 0.42% | | Streptococcus dysgalactiae MLSB | 1 | 0.42% | | Streptococcus spp. | 1 | 0.42% |
|
|
Abbreviations: MSS: methicillin-susceptible Staphylococcus; MDR: multiple drug resistant; MLSB: macrolide-lincosamide-streptogramin B resistance; MRSA: methicillin-resistant Staphylococcus aureus; HLAR: high-level aminoglycoside resistance; ESBL: extended spectrum beta-lactamase; AMP C: AmpC beta-lactamases; VRE: vancomycin-resistant enterococci; MBL: metallo-beta-lactamase.
|
